Systemic Treatments for Alopecia Areata Registry

ConditionsAlopecia Areata Alopecia Totalis Alopecia Universalis Hair Loss Hair Diseases Alopecia Alopecia Drugs Autoimmune Diseases

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age16+

SponsorErasmus Medical Center

About this trial

A multicenter prospective registry (STA2R) is conducted to assess systemic treatments for alopecia areata, focusing on effectiveness, safety, and long-term outcomes.

Eligibility criteria

Qualifiers

Diagnosed with alopecia areata;

Starting/using a systemic treatment for alopecia areata;

Informed consent for registry participation obtained from patient and/or caretaker.

Disqualifiers

Not sufficiently capable of understanding the Dutch language;

Not willing to participate.

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Erasmus Medical Center

Lead sponsor

Source ClinicalTrials.gov